statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MIMEDX Provides Update on AXIOFILL  Request for Designation ( RFD ) from FDA

Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the...

MiMedx Group (MDXG, $7.83) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 25, 2024

This is a Bearish indicator signaling MDXG's price could decline from here. Traders may explore shorting the stock or put options...

MiMedx Group (MDXG, $8.03) entered Downtrend as Momentum indicator drops below 0 level on Mar 22, 2024

This indicator may be signaling that MDXG's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

MiMedx Group (MDXG, $8.03) price exceeded its 50-day Moving Average on March 22, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

MiMedx Group (MDXG, $8.16) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 21, 2024

This is a Bullish indicator signaling MDXG's price could rise from here. Traders may explore going long the stock or buying call options...

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Exclusive agreement provides MIMEDX with rights to commercialize 510(k) cleared, bovine-derived collagen matrix particulate that is indicated for the management of exudating woundsMARIETTA, Ga...

MIMEDX Introduces E-Commerce and Account Management Platform

Designed to Streamline Ordering, Payment Processing, and Reimbursement SubmissionsMARIETTA, Ga., March 13, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ( MIMEDX or the Company...

MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Rating of "Buy" by Analysts

MiMedx Group, Inc. (NASDAQ:MDXG  Get Free Report) has received a consensus recommendation of Buy from the four analysts that are currently covering the stock, Marketbeat.com...

MiMedx Group (MDXG, $8.01) price exceeded its 50-day Moving Average on March 11, 2024

MiMedx Group (MDXG, $8.15) entered Downtrend as Momentum indicator drops below 0 level on Mar 07, 2024

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Volume	628,757.00
52-Wk High	$9.27
52-Wk Low	$5.57

MDXG Mimedx Group Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community